Contact Us

The world's first and only minimally invasive platform for the Laminoplasty procedure.

Get back your quality of life, better and faster... with Spectrum Spine

spectrum icon

Spectrum Spine Solutions

For spine surgeons who believe in minimally invasive surgery, Spectrum Spine offers spinal solutions that minimize soft tissue damage and give the body its best chance at recovery.

Spectrum Spine’s first FDA Cleared product delivers on that mission with the Bridge™ tubular approach Laminoplasty system, designed to preserve nerve, vasculature and muscle tissue, reduce operative complications and restore pain-free function. This is the world's first and only minimally invasive platform for the Laminoplasty procedure, and promises to move Laminoplasty from the inpatient to the outpatient setting, with better pain and function outcomes, lower rate of infection and re-operation, and less narcotic usage.

Doctor examining a spine
Why does Spectrum Spine Exist
Spectrum Spine Mission

Patented and FDA Cleared Spectrum Technology

“The biggest problem with the laminoplasty procedure is that it requires a very large and destructive incision over many levels of the spine which can cause many problems. “

BRIDGE™ Laminoplasty System

BRIDGE™ Laminoplasty System

The existing laminoplasty procedure typically mandates a 3- to 4-day hospital stay, is incredibly painful, and strips all the muscle from the spine in a large region.
ugh
How The BRIDGE™ Laminoplasty System Works

Opportunity awaits you...

Info on these and other IP portfolio in investor section; accredited investors can access more info through our investor portal.

 

white spectrum icon

Spectrum Spine Team

Click Image for Bio
Dr. Jim Robinson
Founder

After 20+ years driving the evolution of minimally invasive surgeries, Dr. Robinson observed the medical device industry’s bias shift from technology-based device development toward copycat devices, and valuing sales over innovation. Knowing his ideas could improve patient outcomes by further reducing the tissue damage that slows the body’s recovery process, he spent a sabbatical achieving his MBA and designing the products that he envisioned would overcome frustrations and failures of the available alternatives. The result of that time was a graduation at the top of his Emory MBA class, dozens of patents, and 7 new spinal surgical devices ready for market, or far along in the development and FDA processes. The time has now come for this mature and valuable, self-funded collection of device systems to be brought to market. We will also work closely with the highest caliber spinal surgeons to continue to innovate, and to remain at the pinnacle of technology development.

Jim is also active with non-profit groups and has donated much time within the U.S. and in other countries providing expert neurosurgical care to those in need. He is on the Board of Directors of HOI, Inc, an NGO active in Central America, and is an active leader in The Boy Scouts of America.
dr-jim-robinson-min.jpg

Dr. Jim Robinson

Founder
Phil R. Powell
Vice President of Sales

Founder of one of the largest medical distributorships in the country, Phillip Powell has over 23+ years of experience in the Medical Sales and Distribution in the healthcare industry. Mr. Powell’s sales expertise and experience as a sales executive in the healthcare and technology markets lead him to his successes in selling technical team solutions and surgical instruments and implants to the Orthopedic market.

Mr. Powell is a trusted advisor of many organizations and has helped numerous senior executives define and execute strategies that have proven to dominate the market. His dependable and self-motivated characteristics along with his ability to adapt to changing situations led him to work with some of the largest medical device manufacturers in the world, delivering record sales and launching countless new products and technologies.

Phillip is a graduate of Stephen F Austin State University, where he earned a Bachelor of Science in Business Administration. He is a proud member of the Sigma Chi Fraternity and a dedicated baseball player in his years at the university and is a proud father of three girls. Through his education and decades of experience, Mr. Powell has become a well-known name in the industry and utilizes his knowledge and skill to be an inspired leader who pays close attention to detail, providing ongoing training and improvement goals for his team.

phil-powell2.jpg

Phil R. Powell

VP of Sales
Tim Ganey
Chief Scientific Advisor

Tim Ganey joined the Vivex Biologics team in November 2017 as its Chief Technology Officer following an extended career at Atlanta Medical Center where he served as Director of Orthopedic Research for the residency training program and Director of the Atlanta Learning Center. Additionally, he was a founder and Chief Technical Officer, SpinPlant GmbH, Leipzig, Germany, maintaining a Faculty Appointment at the TRM Facility in Leipzig Germany, and an associate faculty member at Nova Southeastern, Ft. Lauderdale, FL. As President of the US division of co.don Tissue Engineering, he guided a team that developed and commercialized a portfolio of cell-based therapeutics for cartilage, bone, and the first clinically available biologic for intervertebral disc in 1999.


Dr. Ganey has been instrumental in several technology development initiatives, among them the use of cell-based therapeutics, electric field transduction, additive manufacturing (3D printing), and prescribed matrices for regenerative medicine. Patents issues include work stemming from pulsed-field delivery, artificial matrices for bone regeneration, electro-spinning methods and materials, mimetic material modification using photoactive lasers, stem cell procurement and purification, and exosome elaboration. His efforts are fully aligned with the shifting paradigm supporting regenerative treatments for effective patient care – translation as the engine of implementation.                                

tim-ganey.png

Tim Ganey

Sr. Scientific Advisor
Spectrum Spine Press Release

Our Latest Press Release

Spectrum Announces Acquisition of Unique Surface Technology for Spinal Trauma

Spectrum Spine acquires highly unique, exciting surplus technology and begins spinal trauma operations.

ATLANTA, June 2, 2021 -- Spectrum Spine, spinal device supplier and leader in the development of spinal surgical device inventions, announced that it has acquired a highly unique and proprietary surface technology for spinal trauma and has begun operations with the device.

BIOBraille™ is a state-of-the-art surface technology with 14 related patents, exclusively licensed to Spectrum Spine. It integrates prescriptive laser technology and is designed to improve patient outcomes in spinal operations.

"We are thrilled to add this game-changing, proprietary technology to the Spectrum Spine portfolio of innovative spinal implants and pleased to have the opportunity to bring Dr. Ganey's brilliant work to clinical implementation."

Dr. Jim Robinson, Spectrum's founder, and Chief Technical Officer.

 This unique surface technology will be added to Spectrum Spine's portfolio of spinal solutions that includes the Bridge™ MIS tubular approach Laminoplasty System, designed to preserve nerve, vasculature, and muscle tissue, reduce operative complications, and restore pain-free function. With this acquisition, Spectrum Spine will continue to provide patients with better pain and function outcomes and lower infection and re-operation rates.

The technology holds great promise to provide unsurpassed bone growth activation in spinal and orthopedic devices that may reduce inflammation, speed the process of strong and durable fusion, and lead to superior outcomes for patients having spinal surgery.

Get In Touch

Invalid Input
Please let us know your name.
Please let us know your name.
Please let us know your email address.
Please let us know your phone number.
Please let us know your message.

Mobile Menu

Contact Us